Daniel B Brown

Summary

Publications

  1. ncbi request reprint Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies
    Daniel B Brown
    Mallinckrodt Institute of Radiology, St Louis, Missouri 63110, USA
    J Vasc Interv Radiol 17:217-23. 2006
  2. doi request reprint Hepatic metastasis from uveal melanoma: angiographic pattern predictive of survival after hepatic arterial chemoembolization
    Pouya N Dayani
    Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, MO 63110, USA
    Arch Ophthalmol 127:628-32. 2009
  3. ncbi request reprint Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Washington University Medical Center, 510 South Kingshighway Boulevard, St Louis, Missouri 63110, USA
    J Vasc Interv Radiol 16:1661-6. 2005
  4. doi request reprint Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation
    William C Chapman
    Department of Surgery, Section of Abdominal Transplantation, Washington University School of Medicine, St Louis, MO 63110, USA
    Ann Surg 248:617-25. 2008
  5. doi request reprint Chemoembolization of hepatocellular carcinoma: patient status at presentation and outcome over 15 years at a single center
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO, USA
    AJR Am J Roentgenol 190:608-15. 2008
  6. ncbi request reprint Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri, USA
    J Vasc Interv Radiol 18:1469-78. 2007
  7. ncbi request reprint Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival
    Ankit Bharat
    Department of Surgery, Section of Abdominal Transplantation, Washington University School of Medicine, 660 S, Euclid Avenue, St Louis, MO 63110, USA
    J Am Coll Surg 203:411-20. 2006
  8. ncbi request reprint Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri, USA
    J Vasc Interv Radiol 20:S425-34. 2009
  9. ncbi request reprint Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri 63110, USA
    J Vasc Interv Radiol 17:225-32. 2006
  10. ncbi request reprint Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors
    Alexander S Ho
    Division of Interventional Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 S Kingshighway Blvd, Box 8131, Saint Louis, MO 63110, USA
    AJR Am J Roentgenol 188:1201-7. 2007

Collaborators

Detail Information

Publications26

  1. ncbi request reprint Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies
    Daniel B Brown
    Mallinckrodt Institute of Radiology, St Louis, Missouri 63110, USA
    J Vasc Interv Radiol 17:217-23. 2006
  2. doi request reprint Hepatic metastasis from uveal melanoma: angiographic pattern predictive of survival after hepatic arterial chemoembolization
    Pouya N Dayani
    Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, MO 63110, USA
    Arch Ophthalmol 127:628-32. 2009
    ..To identify clinical features associated with survival after hepatic arterial chemoembolization (HACE) for uveal melanoma metastasis...
  3. ncbi request reprint Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Washington University Medical Center, 510 South Kingshighway Boulevard, St Louis, Missouri 63110, USA
    J Vasc Interv Radiol 16:1661-6. 2005
    ..The optimal embolic agent for transhepatic arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) has not been identified. This study reports outcomes of TACE for HCC with Gelfoam powder and polyvinyl alcohol (PVA)...
  4. doi request reprint Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation
    William C Chapman
    Department of Surgery, Section of Abdominal Transplantation, Washington University School of Medicine, St Louis, MO 63110, USA
    Ann Surg 248:617-25. 2008
    ....
  5. doi request reprint Chemoembolization of hepatocellular carcinoma: patient status at presentation and outcome over 15 years at a single center
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO, USA
    AJR Am J Roentgenol 190:608-15. 2008
    ....
  6. ncbi request reprint Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri, USA
    J Vasc Interv Radiol 18:1469-78. 2007
    ....
  7. ncbi request reprint Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival
    Ankit Bharat
    Department of Surgery, Section of Abdominal Transplantation, Washington University School of Medicine, 660 S, Euclid Avenue, St Louis, MO 63110, USA
    J Am Coll Surg 203:411-20. 2006
    ..In this study, we investigated the efficacy of LRT as a strategy to improve longterm survival after transplantation...
  8. ncbi request reprint Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri, USA
    J Vasc Interv Radiol 20:S425-34. 2009
    ....
  9. ncbi request reprint Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri 63110, USA
    J Vasc Interv Radiol 17:225-32. 2006
  10. ncbi request reprint Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors
    Alexander S Ho
    Division of Interventional Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 S Kingshighway Blvd, Box 8131, Saint Louis, MO 63110, USA
    AJR Am J Roentgenol 188:1201-7. 2007
    ..Long-term outcome data are limited. We present our experience in the use of hepatic artery chemoembolization in the treatment of patients with hepatic metastasis from neuroendocrine tumors...
  11. ncbi request reprint Hepatic arterial chemoembolization for management of metastatic melanoma
    Karun V Sharma
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO, USA
    AJR Am J Roentgenol 190:99-104. 2008
    ..However, the reports of outcomes are limited. We present our outcomes with hepatic arterial chemoembolization for metastasis of stage 4 melanoma...
  12. ncbi request reprint Quality improvement guidelines for the treatment of lower extremity deep vein thrombosis with use of endovascular thrombus removal
    Suresh Vedantham
    Department of Radiology, Mallinckrodt Institute of Radiology, Saint Louis, Missouri, USA
    J Vasc Interv Radiol 17:435-47; quiz 448. 2006
  13. ncbi request reprint Practice building in interventional oncology
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, Saint Louis, MO 63110, USA
    Tech Vasc Interv Radiol 9:90-5. 2006
    ..In this article, practical methods to target and expand individual practices are addressed along with ways to use physician extenders to maximize efficiency in practice...
  14. ncbi request reprint Radiofrequency ablation of recurrent hepatocellular carcinoma in a patient after liver transplantation: two-year follow-up
    Chanda K Ho
    Department of Internal Medicine, Washington University School of Medicine, 510 South Kingshighway Boulevard, Box 8131, St Louis, Missouri 63110, USA
    J Vasc Interv Radiol 18:1451-3. 2007
    ....
  15. doi request reprint Salvage radioembolization of liver-dominant metastases with a resin-based microsphere: initial outcomes
    Jourdan E Stuart
    Washington University School of Medicine, St Louis, Missouri, USA
    J Vasc Interv Radiol 19:1427-33. 2008
    ..The present report describes the outcomes in a cohort of patients with metastatic liver tumors treated with a resin-based microsphere agent...
  16. ncbi request reprint Patient factors affecting thermal lesion size with an impedance-based radiofrequency ablation system
    Craig B Glaiberman
    Mallinckrodt Institute of Radiology, 510 South Kingshighway Boulevard, Box 8131, St Louis, Missouri 63110, USA
    J Vasc Interv Radiol 16:1341-8. 2005
    ..To evaluate factors that affect the size of the thermal lesion created from radiofrequency ablation (RFA) with an impedance-based system...
  17. ncbi request reprint Tumor lysis syndrome after radiofrequency ablation of hepatocellular carcinoma
    Shannon G Lehner
    St Louis University School of Medicine, St Louis, MO, USA
    AJR Am J Roentgenol 185:1307-9. 2005
  18. ncbi request reprint Pharmacokinetics after endovascular lung perfusion with Cisplatin
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 South Kingshighway Boulevard, Box 8131, St Louis, Missouri 63110, USA
    J Vasc Interv Radiol 17:883-8. 2006
    ..Endovascular lung perfusion (ELP) is a technique designed to deliver high doses of cisplatin via the pulmonary artery for the treatment of lung tumors. The purpose of the current study was to evaluate variables that affect adduct formation...
  19. ncbi request reprint Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Siteman Cancer Center, Washington University Medical Center, 510 South Kingshighway Boulevard, St Louis, Missouri 63110, USA
    J Vasc Interv Radiol 15:1209-18. 2004
    ..To compare the value of the Child-Pugh and Model for End-stage Liver Disease (MELD) scores to predict patient survival rates after transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC)...
  20. ncbi request reprint Endovascular treatment of vertebral artery steal syndrome from an arteriovenous fistula between the internal mammary artery and superior vena cava
    Jessica S Huang
    Washington University School of Medicine, Mallinckrodt Institute of Radiology, St Louis, Missouri 63110, USA
    J Vasc Interv Radiol 17:359-62. 2006
    ..Angiography demonstrated the AV fistula and antegrade flow through the vertebral artery. Coil embolization of this high-flow fistula resulted in complete resolution of symptoms...
  21. ncbi request reprint Persistent urine leak after cryoablation of a renal tumor in a patient with an ileal conduit
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 S Kingshighway Blvd, Box 8131, St Louis, MO 63110, USA
    J Vasc Interv Radiol 18:1324-7. 2007
    ..The presence of an ileal conduit may present an increased risk of urinary fistula after thermal ablation...
  22. ncbi request reprint Power injection of microcatheters: an in vitro comparison
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Washington University Medical Center, 510 South Kingshighway Boulevard, St Louis, Missouri 63110, USA
    J Vasc Interv Radiol 16:101-6. 2005
    ..To determine the tolerance of 0.021-inch and 0.027-inch microcatheters to power injection in an in vitro flow model...
  23. doi request reprint Percutaneous biopsy before interventional oncologic therapy: current status
    Daniel B Brown
    Division of Cardiovascular and Interventional Radiology, Thomas Jefferson University, 111 South 11th Street, Philadelphia, PA 19107, USA
    J Vasc Interv Radiol 19:973-9. 2008
  24. ncbi request reprint Use of a hybrid fluoroscopic/three-dimensional tomographic unit to assist in targeting a hepatic metastasis for thermal ablation
    Dennis E Der
    J Vasc Interv Radiol 18:583-4. 2007
  25. ncbi request reprint Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy
    Ravi Murthy
    Division of Diagnostic Imaging, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    J Vasc Interv Radiol 18:553-61; quiz 562. 2007
    ..Our aim is to increase the understanding of the role of various imaging and preventative techniques in minimizing this undesired effect...
  26. ncbi request reprint Endovascular lung perfusion using high-dose cisplatin: uptake and DNA adduct formation in an animal model
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Alvin J Siteman Cancer Center, St Louis, MO 63110, USA
    Oncol Rep 11:237-43. 2004
    ..Further study of ELP evaluating the acute and chronic effects of repeated treatment administration is warranted...